메뉴 건너뛰기




Volumn 138, Issue 6, 2010, Pages 1333-1339

Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIMETHATE;

EID: 77957569216     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0463     Document Type: Article
Times cited : (220)

References (37)
  • 1
  • 2
    • 0015999159 scopus 로고
    • Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B
    • Duncan IB. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother. 1974;5(1):9-15.
    • (1974) Antimicrob Agents Chemother , vol.5 , Issue.1 , pp. 9-15
    • Duncan, I.B.1
  • 3
    • 0014801502 scopus 로고
    • Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy
    • Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970;72(6):857-868.
    • (1970) Ann Intern Med , vol.72 , Issue.6 , pp. 857-868
    • Koch-Weser, J.1    Sidel, V.W.2    Federman, E.B.3    Kanarek, P.4    Finer, D.C.5    Eaton, A.E.6
  • 4
    • 0013964173 scopus 로고
    • Acute renal failure associated with sodium colistimethate treatment
    • Elwood CM, Lucas GD, Muehrcke RC. Acute renal failure associated with sodium colistimethate treatment. Arch Intern Med. 1966;118(4):326-334.
    • (1966) Arch Intern Med , vol.118 , Issue.4 , pp. 326-334
    • Elwood, C.M.1    Lucas, G.D.2    Muehrcke, R.C.3
  • 5
    • 0014966476 scopus 로고
    • Effects of large doses of colistin sulphomethate sodium on renal function
    • Price DJ, Graham DI. Effects of large doses of colistin sulphomethate sodium on renal function. BMJ. 1970;4(5734):525-527.
    • (1970) BMJ , vol.4 , Issue.5734 , pp. 525-527
    • Price, D.J.1    Graham, D.I.2
  • 7
    • 33744454666 scopus 로고    scopus 로고
    • Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
    • Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006;50(6):1953-1958.
    • (2006) Antimicrob Agents Chemother , vol.50 , Issue.6 , pp. 1953-1958
    • Bergen, P.J.1    Li, J.2    Rayner, C.R.3    Nation, R.L.4
  • 8
    • 0035118424 scopus 로고    scopus 로고
    • In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    • Li J, Turnidge J, Milne R, Nation RL, Coulthard K. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 2001;45(3):781-785.
    • (2001) Antimicrob Agents Chemother , vol.45 , Issue.3 , pp. 781-785
    • Li, J.1    Turnidge, J.2    Milne, R.3    Nation, R.L.4    Coulthard, K.5
  • 9
    • 0001526503 scopus 로고
    • Serum concentration of colistin in patients with normal and impaired renal function
    • Mackay DN, Kaye D. Serum concentration of colistin in patients with normal and impaired renal function. N Engl J Med. 1964;270:394-397.
    • (1964) N Engl J Med , vol.270 , pp. 394-397
    • Mackay, D.N.1    Kaye, D.2
  • 10
    • 0014739503 scopus 로고
    • Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals
    • Froman J, Gross L, Curatola S. Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals. J Urol. 1970;103(2):210-214.
    • (1970) J Urol , vol.103 , Issue.2 , pp. 210-214
    • Froman, J.1    Gross, L.2    Curatola, S.3
  • 11
    • 0035949823 scopus 로고    scopus 로고
    • A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversedphase high-performance liquid chromatography
    • Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K, Johnson DW. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversedphase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2001;761(2):167-175.
    • (2001) J Chromatogr B Biomed Sci Appl , vol.761 , Issue.2 , pp. 167-175
    • Li, J.1    Milne, R.W.2    Nation, R.L.3    Turnidge, J.D.4    Coulthard, K.5    Johnson, D.W.6
  • 12
    • 0036784069 scopus 로고    scopus 로고
    • Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography
    • Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K, Valentine J. Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography. Antimicrob Agents Chemother. 2002;46(10):3304-3307.
    • (2002) Antimicrob Agents Chemother , vol.46 , Issue.10 , pp. 3304-3307
    • Li, J.1    Milne, R.W.2    Nation, R.L.3    Turnidge, J.D.4    Coulthard, K.5    Valentine, J.6
  • 13
    • 33747362870 scopus 로고    scopus 로고
    • Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
    • Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589-601.
    • (2006) Lancet Infect Dis , vol.6 , Issue.9 , pp. 589-601
    • Li, J.1    Nation, R.L.2    Turnidge, J.D.3
  • 14
    • 17644389620 scopus 로고    scopus 로고
    • Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
    • Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333-1341.
    • (2005) Clin Infect Dis , vol.40 , Issue.9 , pp. 1333-1341
    • Falagas, M.E.1    Kasiakou, S.K.2
  • 15
    • 0033674317 scopus 로고    scopus 로고
    • The treatment of respiratory pseudomonas infection in cystic fibrosis: What drug and which way?
    • Banerjee D, Stableforth D. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Drugs. 2000;60(5):1053-1064.
    • (2000) Drugs , vol.60 , Issue.5 , pp. 1053-1064
    • Banerjee, D.1    Stableforth, D.2
  • 16
    • 0348149151 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
    • Li J, Coulthard K, Milne R, et al. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J Antimicrob Chemother. 2003;52(6):987-992.
    • (2003) J Antimicrob Chemother , vol.52 , Issue.6 , pp. 987-992
    • Li, J.1    Coulthard, K.2    Milne, R.3
  • 17
    • 45149094778 scopus 로고    scopus 로고
    • Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gramnegative bacilli infections: A prospective, open-label, uncontrolled study
    • Markou N, Markantonis SL, Dimitrakis E, et al. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gramnegative bacilli infections: a prospective, open-label, uncontrolled study. Clin Ther. 2008;30(1):143-151.
    • (2008) Clin Ther , vol.30 , Issue.1 , pp. 143-151
    • Markou, N.1    Markantonis, S.L.2    Dimitrakis, E.3
  • 18
    • 27644585168 scopus 로고    scopus 로고
    • Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration
    • Li J, Rayner CR, Nation RL, et al. Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother. 2005;49(11):4814- 4815.
    • (2005) Antimicrob Agents Chemother , vol.49 , Issue.11 , pp. 4814-4815
    • Li, J.1    Rayner, C.R.2    Nation, R.L.3
  • 19
    • 67749145541 scopus 로고    scopus 로고
    • Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria
    • Plachouras D, Karvanen M, Friberg LE, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother. 2009;53(8):3430-3436.
    • (2009) Antimicrob Agents Chemother , vol.53 , Issue.8 , pp. 3430-3436
    • Plachouras, D.1    Karvanen, M.2    Friberg, L.E.3
  • 20
    • 33744823760 scopus 로고    scopus 로고
    • The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
    • Pea F, Viale P. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis. 2006;42(12):1764-1771.
    • (2006) Clin Infect Dis , vol.42 , Issue.12 , pp. 1764-1771
    • Pea, F.1    Viale, P.2
  • 21
    • 12944307865 scopus 로고    scopus 로고
    • Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness
    • Mehrotra R, De Gaudio R, Palazzo M. Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness. Intensive Care Med. 2004;30(12):2145-2156.
    • (2004) Intensive Care Med , vol.30 , Issue.12 , pp. 2145-2156
    • Mehrotra, R.1    De Gaudio, R.2    Palazzo, M.3
  • 23
    • 51549106318 scopus 로고    scopus 로고
    • Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
    • Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Høiby N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros. 2008;7(5):391-397.
    • (2008) J Cyst Fibros , vol.7 , Issue.5 , pp. 391-397
    • Johansen, H.K.1    Moskowitz, S.M.2    Ciofu, O.3    Pressler, T.4    Høiby, N.5
  • 24
    • 40049095690 scopus 로고    scopus 로고
    • Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: Studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
    • Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother. 2008;61(3):636-642.
    • (2008) J Antimicrob Chemother , vol.61 , Issue.3 , pp. 636-642
    • Bergen, P.J.1    Li, J.2    Nation, R.L.3    Turnidge, J.D.4    Coulthard, K.5    Milne, R.W.6
  • 25
    • 77149178390 scopus 로고    scopus 로고
    • Elucidation of pharmacolinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in mutine thigh and lung infection model
    • Dudhani RV, Turnidge JD, Coulthard K, et al. Elucidation of pharmacolinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in mutine thigh and lung infection model. Antimicrob Agents Chemother. 2010;54(3):1117-1124.
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.3 , pp. 1117-1124
    • Dudhani, R.V.1    Turnidge, J.D.2    Coulthard, K.3
  • 26
    • 24144457739 scopus 로고    scopus 로고
    • Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
    • Tam VH, Schilling AN, Vo G, et al. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49(9):3624-3630
    • (2005) Antimicrob Agents Chemother , vol.49 , Issue.9 , pp. 3624-3630
    • Tam, V.H.1    Schilling, A.N.2    Vo, G.3
  • 27
    • 45749155186 scopus 로고    scopus 로고
    • Intravenous colistimethate for multidrugresistant Gram-negative bacteria
    • Zavascki AP, Li J. Intravenous colistimethate for multidrugresistant Gram-negative bacteria. Lancet Infect Dis. 2008;8(7):403-405.
    • (2008) Lancet Infect Dis , vol.8 , Issue.7 , pp. 403-405
    • Zavascki, A.P.1    Li, J.2
  • 28
    • 23744504983 scopus 로고    scopus 로고
    • Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: A prospective cohort study
    • Reina R, Estenssoro E, Sáenz G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med. 2005;31(8):1058-1065.
    • (2005) Intensive Care Med , vol.31 , Issue.8 , pp. 1058-1065
    • Reina, R.1    Estenssoro, E.2    Sáenz, G.3
  • 29
    • 34447130382 scopus 로고    scopus 로고
    • Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: A matched case-control study
    • Kallel H, HergafiL, Bahloul M, et al. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med. 2007;33(7):1162-1167.
    • (2007) Intensive Care Med , vol.33 , Issue.7 , pp. 1162-1167
    • Kallel, H.1    Hergafi, L.2    Bahloul, M.3
  • 30
    • 13844311296 scopus 로고    scopus 로고
    • Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: The renaissance of an old antibiotic
    • Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect. 2005;11(2):115-121.
    • (2005) Clin Microbiol Infect , vol.11 , Issue.2 , pp. 115-121
    • Michalopoulos, A.S.1    Tsiodras, S.2    Rellos, K.3    Mentzelopoulos, S.4    Falagas, M.E.5
  • 31
    • 23644439540 scopus 로고    scopus 로고
    • Eradication of early Pseudomonas aeruginosa infection
    • Høiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005;4(suppl 2):49-54.
    • (2005) J Cyst Fibros , vol.4 , Issue.SUPPL. 2 , pp. 49-54
    • Høiby, N.1    Frederiksen, B.2    Pressler, T.3
  • 32
    • 77955159963 scopus 로고    scopus 로고
    • Inhaled colistin as adjunctive to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: A comparative cohort study
    • Korbila IP, Michalopoulos A, Rafailidis PI, Nikita D, Samonis G, Falagas ME. Inhaled colistin as adjunctive to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infect. 2010;16(8):1230-1236.
    • (2010) Clin Microbiol Infect , vol.16 , Issue.8 , pp. 1230-1236
    • Korbila, I.P.1    Michalopoulos, A.2    Rafailidis, P.I.3    Nikita, D.4    Samonis, G.5    Falagas, M.E.6
  • 35
    • 33747368398 scopus 로고    scopus 로고
    • Urinary N-acetyl-b-D-glucosaminidase (NAG) in adults with CF - A marker of nephrotoxicity?
    • abstract
    • Etherington C, Conway SP, Peckam DG, et al. Urinary N-acetyl-b-D- glucosaminidase (NAG) in adults with CF - A marker of nephrotoxicity [abstract] ? J Cyst Fibros. 2004;3 (suppl 1):S49.
    • (2004) J Cyst Fibros , vol.3 , Issue.SUPPL. 1
    • Etherington, C.1    Conway, S.P.2    Peckam, D.G.3
  • 36
    • 0015132070 scopus 로고
    • Binding of polymyxin antibiotics to tissues: The major determinant of distribution and persistence in the body
    • Kunin CM, Bugg A. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis. 1971;124(4):394-400.
    • (1971) J Infect Dis , vol.124 , Issue.4 , pp. 394-400
    • Kunin, C.M.1    Bugg, A.2
  • 37
    • 0020106810 scopus 로고
    • The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves
    • Ziv G, Nouws JFM, van Ginneken CAM. The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. J Vet Pharmacol Ther. 1982;5(1):45-58.
    • (1982) J Vet Pharmacol Ther , vol.5 , Issue.1 , pp. 45-58
    • Ziv, G.1    Nouws, J.F.M.2    Van Ginneken, C.A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.